Abstract
Biofilm formation by respiratory pathogen favour their colonization, persistence and virulence. Cigarette smoke have the ability to cause induction and increase in biofilm formation. This quantitative in vitro study is aimed at understanding the dose-dependent change in the biofilm formation, which can be correlated to the degree of virulence of the respiratory pathogens. Materials and Methods:In the present study, 77 respiratory isolates of non-smokers were included. They were processed and exposed to varying concentrations of Cigarette Smoke Extract (CSE).Quantification of biofilm production was done according to the Microtitre dish biofilm formation assay. Fischer’s exact test was used to compare the biofilm production status. Results:We observed that 42[80.77%] isolates out of 52 biofilm producers and 12[48%] isolates out of 25 non-biofilm producers were found to show an increase in Biofilm index (BFI) with exposure to CSE. Among the total of 77 respiratory isolates, 32 isolates accounting for 41.57% [95% CI; 30.6% to 52.6%] showed a dose-related augmentation of biofilm formation on exposure to CSE. Interpretation and Conclusions:Progressive increase of biofilm with increase in concentration of CSE was the major finding. This emphasizes the need to initiate appropriate empirical therapy for smokers at the earliest. Keywords: Biofilm producer, Cigarette smoke extract, CSE, Dose related augmentation, Respiratory pathogens, Staphylococcus aureusa
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.